Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Peripheral arterial intervention · Texas | Peripheral arterial intervention · Florida | |
|---|---|---|
| Surgeons, 2024 | 128 | 132 |
| Medicare fee-for-service cases | 16,813 | 20,074 |
| Growth since 2019 (Medicare FFS) | −7.6%/yr | −3.1%/yr |
| Forecast cases (Medicare FFS) | 19,600 in 2030 | 23,800 in 2030 |
| Forecast growth | +2.6%/yr to 2030 | +2.9%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 7.4 | 8.5 |
| Medicare Advantage share | 59% | 60% |
| Out of hospital | 58% (+6 pts since 2019) | 70% (+7 pts since 2019) |
| Cases per surgeon | 131 | 152 |
| Top 10 surgeons' share | 31% | 42% |
| Surgeons growing | 18 | 30 |
| New since the base year | 19 | 16 |
| Likely to stop billing it | 21 by 2026 | 21 by 2026 |
| Forecast miss, 1 year (procedure) | 8% | 8% |
| Company payments per surgeon | $1,503 | $4,937 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.